Vapreotide (Q4008670)

From Wikidata
Jump to: navigation, search
pharmaceutical drug
edit
Language Label Description Also known as
English
Vapreotide
pharmaceutical drug

    Statements

    1,130.483014±0 atomic mass unit
    1 reference
    C₅₇H₇₀N₁₂O₉S₂
    1 reference
    CC(C)C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=C(C=C4)O)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CC6=CNC7=CC=CC=C76)C(=O)N
    1 reference
    CC(C)[C@H]1C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=C(C=C4)O)NC(=O)[C@@H](CC5=CC=CC=C5)N)C(=O)N[C@@H](CC6=CNC7=CC=CC=C76)C(=O)N
    1 reference

    Identifiers

    0 references
    1 reference
    (4R,7S,10S,13S,16R,19R)-10-(4-Aminobutyl)-N-[(2S)-1-amino-3-(1H-indol-3-yl)-1-oxo-2-propanyl]-16-(4-hydroxybenzyl)-13-(1H-indol-3-ylmethyl)-7-isopropyl-6,9,12,15,18-pentaoxo-19-(D-phenylalanylamino)-1 (English)
    21 September 2016
     
    edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit